PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
Authors
Keywords
-
Journal
JOURNAL OF RADIATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-12-03
DOI
10.1093/jrr/rrz088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peak
- (2019) Hidehiro Hojo et al. ACTA ONCOLOGICA
- Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak
- (2017) Hidehiro Hojo et al. Radiation Oncology
- Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells
- (2016) Takahisa Hirai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
- (2016) Yanyan Jiang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A genetic basis for the variation in the vulnerability of cancer to DNA damage
- (2016) Brian D. Yard et al. Nature Communications
- Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
- (2015) Na Young Jang et al. BMC CANCER
- REV7 counteracts DNA double-strand break resection and affects PARP inhibition
- (2015) Guotai Xu et al. NATURE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy
- (2015) Yuting Lin et al. PHYSICS IN MEDICINE AND BIOLOGY
- In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio
- (2015) Cihan Gani et al. RADIOTHERAPY AND ONCOLOGY
- Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation
- (2015) Andrea O. Fontana et al. RADIOTHERAPY AND ONCOLOGY
- Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
- (2015) Caroline V.M. Verhagen et al. RADIOTHERAPY AND ONCOLOGY
- Targeting DNA damage response in cancer therapy
- (2014) Noriko Hosoya et al. CANCER SCIENCE
- Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
- (2013) Thomas Crosby et al. LANCET ONCOLOGY
- Biological Effects of Proton Radiation: What We Know and Don't Know
- (2013) Swati Girdhani et al. RADIATION RESEARCH
- Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
- (2012) Thomas Ernst Schmid et al. CURRENT GENOMICS
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research
- (2011) Alesia Ivashkevich et al. CANCER LETTERS
- The role of homologous recombination in radiation-induced double-strand break repair
- (2011) Penny A. Jeggo et al. RADIOTHERAPY AND ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now